CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage developer of innovative RNA-targeted therapeutics, will report third quarter 2016 financial results before the NASDAQ Global Market opens on Thursday, October 27, 2016. Subsequently, at 8:00 a.m., Eastern Time, Edward Kaye, M.D., Sarepta’s chief executive officer, Sandy Mahatme, Sarepta’s chief financial officer, and Bo Cumbo, Sarepta’s senior vice president of global commercial development will host a conference call to discuss third quarter financial results and to provide a corporate update.
